As of 2024-07-27, the Intrinsic Value of Dynavax Technologies Corp (DVAX) is
1.17 USD. This DVAX valuation is based on the model Discounted Cash Flows (EBITDA Exit 10Y).
With the current market price of 11.61 USD, the upside of Dynavax Technologies Corp is
%.
The range of the Intrinsic Value is (1.41) - 4.31 USD
DVAX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(86.12) - (18.95) |
(30.22) |
-360.3% |
| DCF (Growth 10y) |
(26.99) - (119.80) |
(42.64) |
-467.3% |
| DCF (EBITDA 5y) |
(2.08) - (0.77) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(1.41) - 4.31 |
1.17 |
-89.9% |
| Fair Value |
1.76 - 1.76 |
1.76 |
-84.87% |
| P/E |
2.16 - 3.55 |
2.77 |
-76.1% |
| EV/EBITDA |
(2.66) - (2.98) |
(2.75) |
-123.7% |
| EPV |
11.79 - 16.28 |
14.03 |
20.8% |
| DDM - Stable |
0.90 - 5.10 |
3.00 |
-74.1% |
| DDM - Multi |
1.27 - 5.64 |
2.08 |
-82.1% |
DVAX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,519.63 |
| Beta |
-0.25 |
| Outstanding shares (mil) |
130.89 |
| Enterprise Value (mil) |
1,610.58 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.34% |
| Cost of Debt |
5.97% |
| WACC |
7.14% |